Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626808 · ClinicalTrials.gov registry record
A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 321,697
- Enrollment target
NCT00626808 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 321,697 participants.
The verdict
NCT00626808 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 321,697 participants
- Enrollment target
Study Summary
This is a retrospective cohort study of children included in a large medical insurance claims database.
Interventions
- DRUG No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321,697 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626808
The ClinicalTrials.gov registry entry for NCT00626808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 321,697 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00626808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00626808 about?
NCT00626808 is a clinical study titled "A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children". This is a retrospective cohort study of children included in a large medical insurance claims database.
What is the current status of trial NCT00626808?
This trial is currently completed. The enrollment target is 321,697 participants. The study started on 2007-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00626808?
The interventions under investigation include: No Intervention (DRUG).
Who is sponsoring clinical trial NCT00626808?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.